We synthesized CeNPs that exhibit considerable biocompatibility and anti‐senescent effects in sarcopenia through their ability to scavenge ROS and downregulate CILP2 in muscle tissues, which may reduce SERPINE1 and phospho‐p21 expression. This evidence concerns the gene CILP2 and sarcopenia.